[go: up one dir, main page]

TR200003468T2 - Borrelia lipoprotein ospa arıtma yöntemi - Google Patents

Borrelia lipoprotein ospa arıtma yöntemi

Info

Publication number
TR200003468T2
TR200003468T2 TR2000/03468T TR200003468T TR200003468T2 TR 200003468 T2 TR200003468 T2 TR 200003468T2 TR 2000/03468 T TR2000/03468 T TR 2000/03468T TR 200003468 T TR200003468 T TR 200003468T TR 200003468 T2 TR200003468 T2 TR 200003468T2
Authority
TR
Turkey
Prior art keywords
purification method
lipoprotein ospa
ospa
borrelia
borrelia lipoprotein
Prior art date
Application number
TR2000/03468T
Other languages
English (en)
Inventor
Desmons Pierre
Liveyns Robert
Mertens Emmanuel
Champluvier Benoit
Plainchamp Dominique
Corazza Yvon
Original Assignee
Smithkline Beecham Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biologicals S.A. filed Critical Smithkline Beecham Biologicals S.A.
Publication of TR200003468T2 publication Critical patent/TR200003468T2/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

Bir bakista,simdiki kesif,Borrelia lipoprotein OspA'nin insanlarin klinik kullanimina uygun bir yöntem saglamaktadir;zviterionik deterjanin varliginda lipoprotein içeren,saf olmayan bir bileske meydana getirmek için,lipoprotein OspA'yi ifade eden,düsman hücre liziz'ini ihtiva eder.
TR2000/03468T 1998-05-26 1999-05-25 Borrelia lipoprotein ospa arıtma yöntemi TR200003468T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9811219.6A GB9811219D0 (en) 1998-05-26 1998-05-26 Novel process

Publications (1)

Publication Number Publication Date
TR200003468T2 true TR200003468T2 (tr) 2002-05-21

Family

ID=10832669

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03468T TR200003468T2 (tr) 1998-05-26 1999-05-25 Borrelia lipoprotein ospa arıtma yöntemi

Country Status (17)

Country Link
EP (1) EP1080109B1 (tr)
JP (1) JP2002516340A (tr)
KR (1) KR20010043817A (tr)
CN (1) CN1311795A (tr)
AT (1) ATE244730T1 (tr)
AU (1) AU752196B2 (tr)
BR (1) BR9910715A (tr)
CA (1) CA2333167A1 (tr)
DE (1) DE69909469T2 (tr)
GB (1) GB9811219D0 (tr)
HU (1) HUP0102774A3 (tr)
IL (1) IL139749A0 (tr)
NO (1) NO20005951L (tr)
PL (1) PL345273A1 (tr)
TR (1) TR200003468T2 (tr)
WO (1) WO1999061473A1 (tr)
ZA (1) ZA200006873B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2077856B1 (en) 2006-11-03 2015-08-12 Intervet International BV Canine lyme disease vaccine
ATE496935T1 (de) * 2007-02-22 2011-02-15 Baxter Int Verfahren zur aufreinigung hydrophober proteine
SI2569009T1 (sl) 2010-05-14 2020-02-28 Baxalta Incorporated Himere OSPA in njihova uporaba v cepivih
AU2013293448A1 (en) 2012-07-27 2015-02-05 Baxalta GmbH Compositions comprising chimeric OspA molecules and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US6221363B1 (en) * 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
JPH06511154A (ja) * 1991-10-18 1994-12-15 コノート ラボラトリーズ インコーポレイテッド 組換えBorreliaタンパクの製造法

Also Published As

Publication number Publication date
EP1080109B1 (en) 2003-07-09
HUP0102774A2 (hu) 2001-11-28
GB9811219D0 (en) 1998-07-22
WO1999061473A1 (en) 1999-12-02
IL139749A0 (en) 2002-02-10
NO20005951L (no) 2001-01-24
DE69909469T2 (de) 2004-04-15
AU752196B2 (en) 2002-09-12
NO20005951D0 (no) 2000-11-24
ATE244730T1 (de) 2003-07-15
KR20010043817A (ko) 2001-05-25
JP2002516340A (ja) 2002-06-04
ZA200006873B (en) 2001-07-05
AU4367999A (en) 1999-12-13
BR9910715A (pt) 2001-01-30
EP1080109A1 (en) 2001-03-07
PL345273A1 (en) 2001-12-03
CN1311795A (zh) 2001-09-05
DE69909469D1 (de) 2003-08-14
CA2333167A1 (en) 1999-12-02
HUP0102774A3 (en) 2003-04-28

Similar Documents

Publication Publication Date Title
AP2000001919A0 (en) Inhibitors of caspases.
WO2001000865A3 (en) Amperometric sensor
ITRM980303A0 (it) Composizione contenente radioisotopi immobilizzati su particelle solide utile in particolare per la biancheria clinica in patologie
EP1033624A4 (en) CHEMICALLY REINFORCED RESIST COMPOSITION
DE69632204T2 (de) Modifizierte polyalkylaluminoxanzusammensetzungen hergestellt aus kohlenstoff-sauerstoff-doppelbindung enthaltende reagenz
TR199901305T2 (tr) Calpain-önleyicileri olarak ketonbenzamidler
ID28329A (id) Komposisi-komposisi yang sesuai untuk sel-sel elektrokimia
DE69525019D1 (de) Cyclosporin enthaltende Weichkapselzusammensetzungen
ATE178053T1 (de) N2s2-chelatoren des hydrazino-typs
EP1112053A4 (en) ORGANOSILICONE COMPOSITIONS FOR PERSONAL CARE
TR200101547T2 (tr) Askomisinleri içeren topik kompozisyonlar
TR200003468T2 (tr) Borrelia lipoprotein ospa arıtma yöntemi
ZA9810371B (en) Th2 cell depletion; compositions; methods.
MY128817A (en) Sheet-shaped pack agent
PL352104A1 (en) Oral composition containing perlite
ES2140673T3 (es) Composicion inmunizadora a base de catalasa de helicobacter pylori.
BR9813897A (pt) Derivados de bifenila como farmacêuticos
NO20021429D0 (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
NO954695L (no) Joderte bor-forbindelser som er anvendelige som röntgenkontrastmidler, og farmasöytiske preparater inneholder disse
EP1121937A4 (en) VACCINE COMPOSITIONS CONTAINING SAPONINE.
DE59908672D1 (de) Teilchenförmig konfektionierte acetonitril-derivate als bleichaktivatoren in festen reinigungsmitteln
TR200103857T2 (tr) İkame [1,4]dizaepino[6,7,1-hi] indol-4-on hazırlanması yöntemi
IT1296564B1 (it) Dispositivo per l'abbattimento della carica batterica in contenitori sigillati.
DE69717147D1 (en) Thrombin inhibitoren
UA30218A (uk) Спосіб визначення активності сполук дезинфектантів у відношенні до збудника сибірки